223 related articles for article (PubMed ID: 18220816)
1. Peripheral TRPV1 receptors as targets for drug development: new molecules and mechanisms.
Gunthorpe MJ; Szallasi A
Curr Pharm Des; 2008; 14(1):32-41. PubMed ID: 18220816
[TBL] [Abstract][Full Text] [Related]
2. TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications.
Avelino A; Cruz F
Naunyn Schmiedebergs Arch Pharmacol; 2006 Jul; 373(4):287-99. PubMed ID: 16721555
[TBL] [Abstract][Full Text] [Related]
3. Disease-related changes in TRPV1 expression and its implications for drug development.
Premkumar LS; Bishnoi M
Curr Top Med Chem; 2011; 11(17):2192-209. PubMed ID: 21671875
[TBL] [Abstract][Full Text] [Related]
4. Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival?
Knotkova H; Pappagallo M; Szallasi A
Clin J Pain; 2008 Feb; 24(2):142-54. PubMed ID: 18209521
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks.
Wong GY; Gavva NR
Brain Res Rev; 2009 Apr; 60(1):267-77. PubMed ID: 19150372
[TBL] [Abstract][Full Text] [Related]
6. Targeting TRPV1 for pain relief: limits, losers and laurels.
Szallasi A; Sheta M
Expert Opin Investig Drugs; 2012 Sep; 21(9):1351-69. PubMed ID: 22780443
[TBL] [Abstract][Full Text] [Related]
7. Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists.
Aghazadeh Tabrizi M; Baraldi PG; Baraldi S; Gessi S; Merighi S; Borea PA
Med Res Rev; 2017 Jul; 37(4):936-983. PubMed ID: 27976413
[TBL] [Abstract][Full Text] [Related]
8. Brain TRPV1: a depressing TR(i)P down memory lane?
Di Marzo V; Gobbi G; Szallasi A
Trends Pharmacol Sci; 2008 Dec; 29(12):594-600. PubMed ID: 18947889
[TBL] [Abstract][Full Text] [Related]
9. Dissecting TRPV1: lessons to be learned?
Grimm C; Aneiros E; de Groot M
Channels (Austin); 2011; 5(3):201-4. PubMed ID: 21654202
[TBL] [Abstract][Full Text] [Related]
10. TRPV1 antagonists: the challenges for therapeutic targeting.
Khairatkar-Joshi N; Szallasi A
Trends Mol Med; 2009 Jan; 15(1):14-22. PubMed ID: 19097938
[TBL] [Abstract][Full Text] [Related]
11. Characterization of SB-705498, a potent and selective vanilloid receptor-1 (VR1/TRPV1) antagonist that inhibits the capsaicin-, acid-, and heat-mediated activation of the receptor.
Gunthorpe MJ; Hannan SL; Smart D; Jerman JC; Arpino S; Smith GD; Brough S; Wright J; Egerton J; Lappin SC; Holland VA; Winborn K; Thompson M; Rami HK; Randall A; Davis JB
J Pharmacol Exp Ther; 2007 Jun; 321(3):1183-92. PubMed ID: 17392405
[TBL] [Abstract][Full Text] [Related]
12. New insights into mechanisms of opioid inhibitory effects on capsaicin-induced TRPV1 activity during painful diabetic neuropathy.
Shaqura M; Khalefa BI; Shakibaei M; Zöllner C; Al-Khrasani M; Fürst S; Schäfer M; Mousa SA
Neuropharmacology; 2014 Oct; 85():142-50. PubMed ID: 24863039
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the TRPV1 channel: current clinical trials and recent patents with focus on neurological conditions.
De Petrocellis L; Moriello AS
Recent Pat CNS Drug Discov; 2013 Dec; 8(3):180-204. PubMed ID: 24330123
[TBL] [Abstract][Full Text] [Related]
14. (R)-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102) blocks polymodal activation of transient receptor potential vanilloid 1 receptors in vitro and heat-evoked firing of spinal dorsal horn neurons in vivo.
Surowy CS; Neelands TR; Bianchi BR; McGaraughty S; El Kouhen R; Han P; Chu KL; McDonald HA; Vos M; Niforatos W; Bayburt EK; Gomtsyan A; Lee CH; Honore P; Sullivan JP; Jarvis MF; Faltynek CR
J Pharmacol Exp Ther; 2008 Sep; 326(3):879-88. PubMed ID: 18515644
[TBL] [Abstract][Full Text] [Related]
15. Design and characterization of a noncompetitive antagonist of the transient receptor potential vanilloid subunit 1 channel with in vivo analgesic and anti-inflammatory activity.
García-Martínez C; Fernández-Carvajal A; Valenzuela B; Gomis A; Van Den Nest W; Ferroni S; Carreño C; Belmonte C; Ferrer-Montiel A
J Pain; 2006 Oct; 7(10):735-46. PubMed ID: 17018334
[TBL] [Abstract][Full Text] [Related]
16. Effects of a TRPV1 agonist capsaicin on respiratory rhythm generation in brainstem-spinal cord preparation from newborn rats.
Tani M; Kotani S; Hayakawa C; Lin ST; Irie S; Ikeda K; Kawakami K; Onimaru H
Pflugers Arch; 2017 Feb; 469(2):327-338. PubMed ID: 27900462
[TBL] [Abstract][Full Text] [Related]
17. The emerging role of TRPV1 in diabetes and obesity.
Suri A; Szallasi A
Trends Pharmacol Sci; 2008 Jan; 29(1):29-36. PubMed ID: 18055025
[TBL] [Abstract][Full Text] [Related]
18. The role of TRPV1 channels in carrageenan-induced mechanical hyperalgesia in mice.
Watanabe M; Ueda T; Shibata Y; Kumamoto N; Ugawa S
Neuroreport; 2015 Feb; 26(3):173-8. PubMed ID: 25590988
[TBL] [Abstract][Full Text] [Related]
19. Presynaptic inhibition of transient receptor potential vanilloid type 1 (TRPV1) receptors by noradrenaline in nociceptive neurons.
Chakraborty S; Elvezio V; Kaczocha M; Rebecchi M; Puopolo M
J Physiol; 2017 Apr; 595(8):2639-2660. PubMed ID: 28094445
[TBL] [Abstract][Full Text] [Related]
20. TRPV
Ives SJ; Park SY; Kwon OS; Gifford JR; Andtbacka RHI; Hyngstrom JR; Richardson RS
Exp Physiol; 2017 Sep; 102(9):1245-1258. PubMed ID: 28681979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
